Compare AANJANEYA LIFECARE with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PIRAMAL ENTERPRISES DR. DATSONS LABS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x -10.9 17.0 - View Chart
P/BV x 0.2 1.1 15.0% View Chart
Dividend Yield % 0.0 1.6 -  

Financials

 DR. DATSONS LABS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PIRAMAL ENTERPRISES
Mar-19
DR. DATSONS LABS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1263,303 3.8%   
Low Rs311,797 1.7%   
Sales per share (Unadj.) Rs133.0716.5 18.6%  
Earnings per share (Unadj.) Rs0.279.7 0.2%  
Cash flow per share (Unadj.) Rs6.6107.9 6.1%  
Dividends per share (Unadj.) Rs028.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.81,477.5 8.7%  
Shares outstanding (eoy) m31.66184.45 17.2%   
Bonus/Rights/Conversions FCCBIS-  
Price / Sales ratio x0.63.6 16.5%   
Avg P/E ratio x516.132.0 1,613.4%  
P/CF ratio (eoy) x11.823.6 50.1%  
Price / Book Value ratio x0.61.7 35.2%  
Dividend payout %035.1 0.0%   
Avg Mkt Cap Rs m2,477470,292 0.5%   
No. of employees `000NA7.8 0.0%   
Total wages/salary Rs m5622,504 0.2%   
Avg. sales/employee Rs ThNM16,899.4-  
Avg. wages/employee Rs ThNM2,877.7-  
Avg. net profit/employee Rs ThNM1,879.9-  
INCOME DATA
Net Sales Rs m4,211132,153 3.2%  
Other income Rs m793,128 2.5%   
Total revenues Rs m4,289135,281 3.2%   
Gross profit Rs m56966,290 0.9%  
Depreciation Rs m2045,202 3.9%   
Interest Rs m43044,097 1.0%   
Profit before tax Rs m1320,119 0.1%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m68,611 0.1%   
Profit after tax Rs m514,701 0.0%  
Gross profit margin %13.550.2 26.9%  
Effective tax rate %48.042.8 112.2%   
Net profit margin %0.111.1 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,852122,742 5.6%   
Current liabilities Rs m6,711310,810 2.2%   
Net working cap to sales %3.3-142.3 -2.4%  
Current ratio x1.00.4 258.5%  
Inventory Days Days16123 697.3%  
Debtors Days Days31839 820.0%  
Net fixed assets Rs m3,673116,904 3.1%   
Share capital Rs m317369 85.8%   
"Free" reserves Rs m3,761272,161 1.4%   
Net worth Rs m4,078272,530 1.5%   
Long term debt Rs m1,671270,196 0.6%   
Total assets Rs m12,633856,261 1.5%  
Interest coverage x1.01.5 70.7%   
Debt to equity ratio x0.41.0 41.3%  
Sales to assets ratio x0.30.2 216.0%   
Return on assets %3.46.9 50.1%  
Return on equity %0.15.4 2.2%  
Return on capital %7.712.4 61.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96415,200 6.3%   
Fx outflow Rs m6074,889 12.4%   
Net fx Rs m35710,312 3.5%   
CASH FLOW
From Operations Rs m1,345-115,975 -1.2%  
From Investments Rs m-2,256-8,265 27.3%  
From Financial Activity Rs m-1,200107,525 -1.1%  
Net Cashflow Rs m-2,111-16,650 12.7%  

Share Holding

Indian Promoters % 4.5 52.9 8.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.0 -  
FIIs % 1.4 26.6 5.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 16.5 570.3%  
Shareholders   20,807 93,274 22.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STRIDES PHARMA SCIENCE  ELDER PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Realty and Telecom Stocks Drag(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is flat while the Hang Seng is down 0.9%.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS